Salivary Gland Poorly Differentiated Carcinoma
1 clinical trials · Condition
◉ Watch Salivary Gland Poorly Differentiated Carcinoma
| Record | Firm | Date |
|---|---|---|
| Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer (NCT00126607) | National Cancer Institute (NCI) | 2005-07-01 |
Track Salivary Gland Poorly Differentiated Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.